| Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer BA Humphries, AC Cutter, JM Buschhaus, YC Chen, T Qyli, ... Breast Cancer Research 22, 1-18, 2020 | 68 | 2020 |
| Plasminogen activator inhibitor 1 (PAI1) promotes actin cytoskeleton reorganization and glycolytic metabolism in triple-negative breast cancer BA Humphries, JM Buschhaus, YC Chen, HR Haley, T Qyli, B Chiang, ... Molecular Cancer Research 17 (5), 1142-1154, 2019 | 58 | 2019 |
| Short-term cellular memory tunes the signaling responses of the chemokine receptor CXCR4 PC Spinosa, BA Humphries, D Lewin Mejia, JM Buschhaus, JJ Linderman, ... Science signaling 12 (589), eaaw4204, 2019 | 30 | 2019 |
| The CXCL12/CXCR7 signaling axis, isoforms, circadian rhythms, and tumor cellular composition dictate gradients in tissue PC Spinosa, KE Luker, GD Luker, JJ Linderman PLoS One 12 (11), e0187357, 2017 | 14 | 2017 |
| Pre-existing cell states control heterogeneity of both EGFR and CXCR4 signaling PC Spinosa, PC Kinnunen, BA Humphries, GD Luker, KE Luker, ... Cellular and Molecular Bioengineering 14, 49-64, 2021 | 7 | 2021 |
| Quantitative modeling predicts competitive advantages of a next generation anti‐NKG2A monoclonal antibody over monalizumab for the treatment of cancer P Spinosa, M Musial‐Siwek, M Presler, A Betts, E Rosentrater, J Villali, ... CPT: Pharmacometrics & Systems Pharmacology 10 (3), 220-229, 2021 | 4 | 2021 |
| Short-term Cellular Memory Tunes CXCR4 Signaling Responses PC Spinosa, BA Humphries, DL Mejia, JM Buschhaus, JJ Linderman, ... Science signaling 12 (589), 2019 | | 2019 |
| Mechanistic Modeling of Cell Signaling Heterogeneity and Chemokine Gradients in Cancer P Spinosa | | 2019 |
